Public disclosures

Feuchtwang Ilan

Company insiders · Chief Legal Officer, Secretary · Cytek Biosciences, Inc.

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-12.Following & alerts
Reported transaction lines
1
Buy lines
0
Sell lines
0

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-111

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
Feuchtwang Ilan

Chief Legal Officer, Secretary · Cytek Biosciences, Inc.

CTKB

Cytek Biosciences, Inc.

Equity grant or award
Filing details

SEC transaction code A

Restricted Stock Units · Derivative security · Direct ownership · Reported balance after transaction: 25745 · Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. · The RSUs shall vest and settle into common stock over 4 years, with 12/48 of the RSUs vesting on November 18, 2027; 4/48 of the RSUs vesting on March 10, 2028 and each March 10 thereafter; 2/48 of the RSUs vesting on May 18, 2028 and each May 18 thereafter; 3/48 of the RSUs vesting on August 18, 2028 and each August 18 thereafter, and 3/48 of the RSUs vesting on November 18, 2028 and each November 18 thereafter, until fully vested (in each case, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan (the "2021 Plan"))).

2026-11-092026-11-12

25,745 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement